Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer.
Grolmusz VK, Karászi K, Micsik T, Tóth EA, Mészáros K, Karvaly G, Barna G, Szabó PM, Baghy K, Matkó J, Kovalszky I, Tóth M, Rácz K, Igaz P, Patócs A.
Grolmusz VK, et al.
Am J Cancer Res. 2016 Sep 1;6(9):2041-2053. eCollection 2016.
Am J Cancer Res. 2016.
PMID: 27725909
Free PMC article.